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Abstract
Background: The aim of this study was to validate the Quality of Life in Adult Cancer Survivors (QLACS) in short-
term Spanish cancer survivor’s patients.
Methods: Patients with breast, colorectal or prostate cancer that had finished their initial cancer treatment 3 years
before the beginning of this study completed QLACS, WHOQOL, Short Form-36, Hospital Anxiety and Depression
Scale, EORTC-QLQ-BR23 and EQ-5D. Cultural adaptation was made based on established guidelines. Reliability was
evaluated using internal consistency and test-retest. Convergent validity was studied by mean of Pearson’s correlation
coefficient. Structural validity was determined by a second-order confirmatory factor analysis (CFA) and Rasch analysis
was used to assess the unidimensionality of the Generic and Cancer-specific scales.
Results: Cronbach’s alpha were above 0.7 in all domains and summary scales. Test-retest coefficients were 0.88 for
Generic and 0.82 for Cancer-specific summary scales.
QLACS generic summary scale was correlated with other generic criterion measures, SF-36 MCS (r = − 0.74) and EQ-VAS
(r = − 0.63). QLACS cancer-specific scale had lower values with the same constructs.
CFA provided satisfactory fit indices in all cases. The RMSEA value was 0.061 and CFI and TLI values were 0.929 and
0.925, respectively. All factor loadings were higher than 0.40 and statistically significant (P < 0.001). Generic summary
scale had eight misfitting items. In the remaining 20 items, the unidimensionality was supported. Cancer Specific
summary scale showed four misfitting items, the remaining showed unidimensionality.
Conclusions: The findings support the validity and reliability of QLACS questionnaire to be used in short-term cancer
survivors.
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Background
Prevalence of patients living with cancer diagnosis is
growing all around the world. The main aim of treat-
ments has usually been to improve the survival of these
patients, but the great success in this objective as well as
with screening tests implies that there are a growing
number of patients surviving this diagnosis and its treat-
ment. Therefore, our concern should be focused on this
new phase: From the end of treatment to five years in
the future, the study of short-term cancer survivors. At
this stage, adverse events have diminished or even disap-
peared and we should confront new aspects of their
care, such as adaptation to the new situation [1] or com-
plications that may arise later.
The impact of treatment on health related quality of
life (HRQoL) for cancer patients is well known. The
questionnaires used in this first phases of the disease such
as Functional Assessment of Cancer Therapy (FACIT) [2]
or European Organization for Research and Treatment of
Cancer (EORTC) [3] are not specifically directed to evalu-
ate the new symptoms and worries that arise after finish-
ing their treatments. Nowadays, a concern that arises is
the measurement of patient reported outcomes (PROs),
which could offer an enormous potential to evaluate,
monitor and possibly to improve the quality and success
of care with these short-term cancer survivors, with new
and sound questionnaires.
In a literature review [4], six instruments devoted to
cancer survivors have been identified. Among them, the
Quality of Life in Adult Cancer Survivors (QLACS) [5]
was found to be the best questionnaire, for its suitable
psychometric properties. The QLACS is a multidimen-
sional questionnaire that has five Cancer-specific do-
mains, which were suggested by patients as relevant to
their lives, along with seven Generic domains that are
relevant to patients with cancer but not limited to
them. It also considers Generic and Cancer-specific
summary scores.
The QLACS questionnaire was originally designed for
use with long-term survivors, but it is now being used in
shorter-term survivors in several studies [6, 7] and has
shown good psychometric properties in 15 months post-
diagnosis cancer survivors [8]. The authors concluded
that although QLACS was designed for patients over
5 years post-diagnosis, it is also valid for shorter-term
survivors. Recently, a new study [9] on the reliability
and validity of QLACS in short-term breast cancer sur-
vivors was published. Authors concluded that it is an
adequate instrument in these patients at 18–24 months
post-diagnosis.
In the light of the reliability and validity of the QLACS
questionnaire for short-term cancer survivors, the aim of
our study was to perform a cross-cultural adaptation of
the QLACS questionnaire for use in Spain and to
validate the Spanish version in terms of its reliability and
validity properties, in a sample of short-term breast,
colorectal or prostate cancer survivors.
Methods
This is a retrospective cohort study. Adult patients with
breast, colorectal or prostate cancer and who had fin-
ished their initial cancer treatment 3 years before the be-
ginning of this study were included. This study took
place in 12 hospitals belonging to the National Health
Service; 3 in Andalusia, 4 in the Canary Islands and 5 in
the Basque Country (Spain). All patients received a letter
informing them about the study and requesting their vol-
untary participation, all of them signed the informed con-
sent. All patients who accepted to take part in the study
were included, given the fact that the inclusion criteria
was to answer the first questionnaire. The Institutional
Review Boards of the Hospitals approved the study. All
the questionnaires were sent to patients via mail in a
range of three-four years after finishing their initial
cancer treatment. Apart from QLACS, the Spanish vali-
dated questionnaires included in this study were,
WHOQOL [10], Short Form-36 [11], Hospital Anxiety
and Depression Scale (HADS) [12], EORTC-QLQ-BR23
[13] and EQ-5D-3 L [14].
Questionnaires
The QLACS questionnaire comprises 47 items measur-
ing 12 domains. There are 7 Generic domains, all of
them with 4 items, negative feelings, positive feelings, cog-
nitive problems, sexual problems, pain, fatigue and social
avoidance. There are also 4 Cancer-specific, appearance
concerns (4 items), financial problems (4 items), distress
over recurrence (4 items) and family-related distress (3
items). There is another domain with 4 items, benefits of
cancer. Each item is scored on a seven-point frequency
scale (1 = never, 2 = seldom, 3 = sometimes, 4 = about as
often as not, 5 = frequently, 6 = very often and 7 = always),
regarding the past four weeks.
Domain scores range from 4 to 28, with higher scores
indicating lower HRQoL (the 3 items domain of family-
related distress score is multiplied by 1.33). The score
for positive feelings is reversed as well as item 1 in fa-
tigue domain. The Generic summary score ranges from
28 to 196 and the Cancer-specific summary score from
16 to 112.
WHOQOL. The WHOQOL-100 assesses individuals’
perceptions of their position in life in the context of the
culture and value systems in which they live and in rela-
tion to their goals, expectations, standards and concerns.
It is a 100-question instrument that yields a multi-
dimensional profile of scores across 6 domains and 24
quality of life sub-domains. In this study we have only
used some sub-domains of the questionnaire
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SF-36 is a 36 item instrument. It provides scores on 8
dimensions and 2 summary scores: the physical compo-
nent summary (PCS) and the mental component sum-
mary (MCS). Scores range from 0 to 100 with a higher
score indicating better health status.
HADS is a questionnaire divided into two subscales
with 7 questions pertaining to symptoms regarding anx-
iety and 7 to symptoms associated with depression. Each
of the 14 items consists of a 4-point Likert scale (ranging
from 0 to 3) that applies to the previous week. Higher
scores indicate worse status.
QLQ-BR23 is the breast module of the EORTC ques-
tionnaire. It is composed of 23 items divided into 4 func-
tional scales and 4 symptoms scales.
EQ-5D-3 L has two sections. The first part, a descrip-
tive system, consists of five questions covering the di-
mensions of mobility, self-care, usual activities, pain/
discomfort, and anxiety/depression. The second part
consists of a 20 cm vertical visual analogue scale (VAS)
ranging from 0 (worse) to 100 (best health). In this
study we have used VAS scale.
The dimensions used in the validation process can be
seen in Table 4.
Adaptation of the QLACS
Firstly, we obtained permission from the original authors
[5] to translate and validate the questionnaire. Transla-
tion and cultural adaptation were made, based on estab-
lished guidelines for cross-cultural adaptation [15]. The
original English questionnaire was independently trans-
lated into Spanish by two translators (one oncologist
and one professional translator) whose native language
was Spanish and who were highly fluent in English. Both
highlighted the difficulty of finding Spanish expressions
that were conceptually equivalent to the original expres-
sions. The two translations were compared and dis-
cussed in a meeting that included the research team and
the translators until a consensus was reached on a single
adapted version (version 1.0). To evaluate the equivalence
of Spanish version 1.0 to the original, it was independently
back-translated to English by two native professional
translators who were highly fluent in Spanish. The two
back translations were compared with the original English
version and a consensus was reached on any necessary
modifications in the Spanish version 1.0. Finally, the re-
vised version of the Spanish QLACS was tested on 10 pa-
tients in order to evaluate how well patients understood
the items, as well as to determine the acceptability and
feasibility of the questionnaire. These patients were not in
the final study sample.
Statistical analysis
The distribution of scores in the Spanish version of the
QLACS was evaluated by analyzing the mean, standard
deviation, proportion of patients with one or more lost
items, observed range, and the ceiling and floor effects
taking into account the accepted values of > 15 % [16].
Reliability
Reliability was analyzed in two ways, internal consistency
by means of Cronbach’s alpha, and item- total (domain
and summary scale) correlations, with values ≥ 0.7 [16]
and ≥ 0.3 respectively, indicating acceptable values. Re-
producibility was analyzed by means of test–retest. Pa-
tients were explicitly asked whether they had experienced
any change in their health status since completing the pre-
vious questionnaire ten days before. When no change was
detected, we calculated the intraclass correlation coeffi-
cients (ICC) for absolute agreement by two-way random
effects model. Values higher than 0.5 are considered ac-
ceptable [17].
Validity
Convergent and discriminant validity was studied by
means of Pearson’s correlation coefficient between some
QLACS domains and other validated questionnaires. We
have been unable to study convergent validity in cogni-
tive problems, financial problems, family-related distress
and benefits of cancer due to the lack of adequate di-
mensions or scales in our study. We have used subscales
of well-known Spanish validated questionnaires such
as WHOQOL [10], Short Form 36 [11], HADS [12],
EORTC-QLQ-BR23 [13] and EQ-5D [14] as criterion
measures.
We hypothesized that QLACS generic summary score
should have negative high correlations with other gen-
eric measures such as SF-36 Mental Component Sum-
mary and Physical Component Summary (MCS and PCS)
or EQ-5D Visual Analogic Scale (VAS). The cancer-
specific summary scale should have lower correlations
with the same generic measures. On the other hand,
QLACS’s domains should have high correlations with
similar domains of the other questionnaires included (e.g.,
QLACS pain with SF-36 bodily pain, appearance concerns
with WHOQOL body image and so on). We considered
convergent validity as moderate when 0.3 > r < 0.49 and
high if r ≥ 0.50 [18].
Construct validity. To study the structural validity of
the questionnaire, two different approaches were used.
First, a second-order confirmatory factor analysis (CFA)
for categorical data was used to confirm the internal
structure, consisting of 12 first-order factors and two
second-order factors. The first-order factors are negative
feelings (NF), positive feelings (PF), cognitive problems
(CP), sexual problems (SP), pain (PN), fatigue (FG), so-
cial avoidance (SA), appearance concerns (AC), financial
problems (FP), distress over recurrence (DOR), family-
related distress (FRD), and benefits of cancer (BOC).
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Then, a second-order Generic factor would affect the
first-order NF, PF, CP, SP, PN, FG and SA factors, and
the other second-order cancer-specific factor would
affect AC, FP, DOR and FRD first-order factors [5]. The
robust weighted least squares estimator was used, and
several fit indices were calculated: the root mean square
error of approximation (RMSEA), for which a value <0.08
was considered acceptable; and the Tucker-Lewis Index
(TLI) and Comparative Fit Index (CFI), both of which
had to be >0.90 to be satisfactory. We also examined
factor loadings, and those ≥0.40 were considered ac-
ceptable [19–21].
Second, we used Rasch analysis with the polytomous
Partial Credit Model because the response scales of the
questionnaire are ordinal with seven response options
[22, 23]. We applied the Rasch method to the Generic
factor, the Cancer-specific factor, and the BOC factor
separately, to ensure that the scales were unidimensional
[24] as this is a fundamental requirement for construct
validity. Unidimensionality was assessed with two indices
of fit, namely the mean square information-weighted
statistic (infit) and the outlier-sensitive statistic (outfit),
with values between 0.7 and 1.3 indicating a good fit
[25], and a principal component analysis (PCA) of the
residuals. Unidimensionality was considered violated if,
besides the first factor, other factors had eigenvalues >3
[26]. We evaluated the ability of the QLACS to define a
distinct hierarchy of items along the measured dimension
by means of an item separation index [24]. A value >2.0 is
comparable to a reliability of 0.80 and considered accept-
able. To detect the presence of differential item function-
ing (DIF), which occurs when different groups within the
sample respond in a different manner to an individual
item [22], we compared different levels of the trait by type
of cancer and gender and age (<65 vs. ≥ 65 years). A
Welch’s t statistically significant at P < 0.05, and a dif-
ference in difficulty ≥0.5 logit were considered to be
noticeable DIF [24]. Residual correlations between items
within a scale were examined for local dependency. Corre-
lations >0.5 between item residuals can indicate that re-
sponses to one item may be determined by others [27].
The functioning of rating scale categories was also exam-
ined for each item. A clearly progressive level of difficulty
across the item categories was considered adequate [24].
Where the response format was disordered, such that
higher response options did not uniformly reflect in-
creases in the underlying construct, this was resolved by
collapsing adjacent response categories.
All effects were considered statistically significant at
P < 0.05. The statistical analyses were performed with
SAS for Windows (version 9.2; SAS Institute, Cary,
NC), Mplus (version 6.1; Muthén et al., 1998–2010),
and Winsteps (version 3.69.1.4; John M. Linacre,
Chicago).
Results
In the translation-back-translation process, we had to
look for advice from the original authors in two points.
Firstly, there were some problems with conceptual mean-
ing of some expressions such as “felt fatigued”, “were
bothered by mood swings” or “felt anxious”. Second, there
was a problem with the labeling of the answer scale.
The intermediate point “about as often as not” was dif-
ficult to adapt. All of them were resolved with the ori-
ginal authors and incorporated in the final version (see
Additional file 1).
707 patients were included in the field study. The
main characteristics of the sample are summarized in
Table 1. The mean (SD) age of the prostate cancer pa-
tients was 70.3 (7.1) with a range from 47 to 87 years.
Breast cancer patients had a mean age (SD) of 60.8
(11.6) with a range of 30–91. Finally, colorectal cancer
patients had a mean age (SD) of 68.7 (9.5) and a range
of 30–91 years. The percentage of women in colorectal
cancer patients was of 35.2 %. The mean scores with
standard deviation of each QLACS domain and summary
scale are displayed in Table 2. There were 4 domains with
floor effect (pain, social avoidance, appearance concerns
Table 1 Sample characteristics (N = 707)
Variable N (%)
Cancer type
Prostate 160 (22.6 %)
Breast 354 (50.1 %)
Colorectal 193 (27.3 %)
Gender (female) 422 (59.7 %)
Age
mean (standard deviation) 65.1 (11.0)
range 30–91
Education
< High school 467 (66.1 %)
High school 130 (18.4 %)
University 76 (10.7 %)
Non-response 34 (4.8 %)
Relationship status
Married/couple 502 (71.0 %)
Single 36 (5.1 %)
Widowed 86 (12.2 %)
Divorced/separated 48 (6.7 %)
Non-response 35 (5.0 %)
Employment status
Retired 347 (49.1 %)
Unemployed 51 (7.2 %)
Employed 256 (36.2 %)
Non-response 53 (7.5 %)
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and financial problems) and one with ceiling effect (fam-
ily-related distress); more than 15 % of patients scoring in
minimum or maximum score respectively. Summary
scales were free of both effects.
Reliability
The Cronbach’s alpha values are shown in Table 2 and
they were above 0.7 in all domains and both summary
scales.
As can be seen in Table 3, in QLACS Generic do-
mains, all corrected item-domain and item-summary
scale correlations were above 0.30 with higher values in
item-domain correlation (range: 0.61–0.86) than in the
item-summary scale correlations (range: 0.38–0.73). The
percentage of missing data was high in the sexual do-
main (from 5.9 to 10.5 %). One item in the social avoid-
ance (7.9 %), positive feelings (14.9 %) and pain (7.2 %)
domains showed values higher than 5 % of missing data
as well.
Regarding Specific domains (Table 3), all item correla-
tions were also above 0.30 but one in financial problems
domain (r = 0.12). As expected, higher values were ob-
served in item-domain correlation, ranging from 0.39 to
0.91 than in the item-summary scales correlations
(range: 0.12 to 0.69). There were a low percentage of
missing data in these specific domains, all below 4.0 %
but one in appearance concern domain (6.5 %).
Considering test-retest reliability (Table 2), the study
was carried out with 137 stable patients and coefficients
ranged from 0.53 to 0.79 in the different domains. The
Generic summary scale had a ICC of 0.88 and the
Cancer-specific summary scale of 0.82.
Convergent validity
Table 4 shows results on the convergent validity analysis.
Considering the absolute size of the correlation coeffi-
cients, and ignoring the direction of correlation, as we hy-
pothesized, QLACS generic summary scale was negatively
correlated with other generic quality of life criterion mea-
sures, SF-36 MCS (r = − 0.74) and EQ-VAS (r = − 0.63)
and this coefficient was lower with SF-36 PCS (r = − 0.57).
On the other hand, QLACS cancer-specific scale had
lower values with the same constructs, ranging from 0.20
to 0.40.
Regarding generic domains, all were highly correlated
with their criterion measures with correlation coeffi-
cients in the range of 0.60 to 0.78. Finally, cancer-
specific domains had a good correlation with values of
0.53 for appearance concerns and 0.60 in the distress
over recurrence domain.
Construct validity
The results of the second-order CFA for the hypothe-
sized model of 12 first-order factors and 2 s-order fac-
tors, the Generic and cancer-specific summary factors,
provided satisfactory fit indices in all cases. The RMSEA
value was 0.061, far below 0.08, and CFI and TLI values













ICC (95 % CI)
n = 137
Negative feelings 692 12.0 (4.8) 4–28 4.7 0.1 0.75 0.77 (069–0.83)
Positive feelings 679 19.9 (5.7) 4–28 0.9 10.2 0.73 0.58 (0.45–0.68)
Cognitive problems 697 10.5 (5.0) 4–28 10.5 0.0 0.78 0.53 (0.40–0.64)
Sexual problems 654 12.7 (6.2) 4–28 9.0 2.3 0.75 0.73 (0.64–0.80)
Pain 689 10.6 (5.9) 4–28 16.7 0.7 0.86 0.76 (0.67–0.82)
Fatigue 694 11.9 (5.3) 4–28 7.6 0.3 0.74 0.76 (0.68–0.82)
Social avoidance 688 9.3 (5.2) 4–28 23.4 0.3 0.82 0.79 (0.71–0.84)
Generic Summary Scale 630 79.0 (28.0) 28–176 0.6 0.2 0.85 0.88 (0.83–0.91)
Appearance concerns 686 9.9 (6.2) 4–28 27.8 0.9 0.77 0.76 (0.68–0.82)
Financial problems 694 6.1 (4.2) 4–28 66.1 0.1 0.75 0.65 (0.53–0.73)
Distress over recurrence 692 17.0 (7.2) 4–28 4.8 8.5 0.81 0.72 (0.63-0.80)
Family-related distress 693 19.3 (7.8) 4–28 5.9 26.4 0.84 0.66 (0.55–0.74)
Cancer specific Summary Scale 678 52.5 (18.1) 16–106 1.3 0.1 0.85 0.82 (0.76–0.87)
Benefits of cancer 692 18.0 (6.6) 4–28 5.2 6.8 0.81 0.67 (0.56–0.76)
SD standard deviation
ICC intraclass correlation coefficient
CI confidence interval
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Table 3 Missing data, item-domain and item summary scale correlations for QLACS domains
Generic Domains Item Missing data (%) Item-domain correlation Item-summary scale correlation
Negative feelings 07 3.4 0.71 0.62
09 3.7 0.70 0.44
19 2.8 0.75 0.69
24 2.8 0.76 0.65
Positive feelings 06 5.0 0.73 0.56
08 3.4 0.75 0.60
22 4.0 0.68 0.40
28 14.9 0.61 0.38
Cognitive problems 02 2.0 0.80 0.54
03 3.0 0.82 0.58
04 2.1 0.79 0.51
23 2.5 0.66 0.51
Sexual problems 10 6.8 0.70 0.40
12 7.1 0.75 0.41
16 5.9 0.75 0.50
26 10.5 0.71 0.53
Pain 13 2.3 0.86 0.67
17 2.8 0.85 0.73
21 4.0 0.82 0.62
27 7.2 0.78 0.64
Fatigue 01 2.3 0.74 0.54
05 3.3 0.77 0.62
11 1.7 0.85 0.70
14 2.4 0.85 0.70
Social Avoidance 15 7.9 0.68 0.45
18 3.0 0.82 0.67
20 2.5 0.76 0.61
25 2.4 0.78 0.58
Specific Domains
Appearance concern 33 1.8 0.83 0.59
35 4.0 0.78 0.51
38 6.5 0.78 0.51
44 2.4 0.66 0.50
Financial problems 30 2.8 0.72 0.31
37 3.5 0.39 0.12
43 2.3 0.91 0.45
45 2.1 0.89 0.45
Distress over Recurrence 36 2.0 0.79 0.63
39 3.8 0.78 0.66
46 2.4 0.81 0.68
47 2.8 0.75 0.63
Family-related distress 31 1.8 0.89 0.64
34 2.5 0.88 0.69
42 2.4 0.82 0.64
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both exceeded 0.90 (0.929 and 0.925, respectively). All
factor loadings were higher than 0.40 and statistically
significant (P < 0.001) (Fig. 1).
Regarding the results of the Rasch analysis for the
Generic scale, eight items showed misfit and were thus
removed from the scale (Table 5). With the remaining
20 items, unidimensionality was supported with infit and
outfit statistics of 0.7 to 1.3, except in item 8 with an
outfit value slightly higher than 1.30. However, the PCA
of the residuals did not yield additional factors with ei-
genvalues higher than 3, implying that the unidimen-
sionality assumption was met. The item separation index
was 7.70, higher than 2, indicating reliability higher than
0.80. The presence of DIF was not detected by type of
cancer, gender or age group (data not shown). Correl-
ation coefficients between residuals were all lower than
0.50, supporting local independence, and the functioning
of the rating scale categories was adequate.
As all sexual items misfit the Generic scale, we under-
took a Rasch analysis separately for this domain (Table 5).
The model showed unidimensionality, an item separation
index of 2, no DIF by type of cancer, gender or age group
(data not shown), and an adequate functioning of rating
scale categories. However, local dependency was detected,
with correlation coefficient between residual higher than
0.50 between the following pairs of items: item 10 and 12
with items 16 and 26.
The results of Rasch analysis for the cancer-specific
scale (Table 5) showed four misfitting items, specifically
items 30, 37, 43 and 45, all of them included in financial
problems domain. After removing these four items, uni-
dimensionality was supported with infit and outfit statis-
tics between 0.7 and 1.3, and with no other factor besides
the first one with eigenvalues higher than 3 in the PCA of
the residuals. The item separation index was 11.89, higher
than 2, correlation coefficients between residuals were all
lower than 0.50, supporting local independence, and the
functioning of the rating scale categories was adequate.
However, the presence of DIF was detected in item 38 by
type of cancer and gender (data not shown), being more
Table 3 Missing data, item-domain and item summary scale correlations for QLACS domains (Continued)
Benefits of cancer 29 1.4 0.79 NA
32 2.1 0.82 NA
40 2.1 0.85 NA
41 3.5 0.70 NA
Table 4 Correlation between some QLACS domains and different criterion measures
QLACS Dimensions Correlation Criterion measures
Negative feelings −0.73 SF-36 (Mental Health)
Positive feelings 0.62 HADS (Depression)
Sexual problems −0.60 WHOQOL(Sex functioning)
Pain −0.69 WHOQOL (Pain)
−0.69 SF-36 (Bodily Pain)
Fatigue 0.78 WHOQOL (Energy/fatigue)
−0.77 SF-36 (Vitality)
Social avoidance 0.60 SF-36 (Social Functioning)
Generic Summary Scale −0.74 SF-36 (Mental Component Summary)
-0.57 SF-36 (Physical Component Summary)
−0.63 EQ-VAS
Appearance concerns −0.53 WHOQOL(Body image)
Distress over recurrence 0.60 EORTC-QLQ-BR23(Future Perspective)
Cancer-specific Summary Scale −0.40 SF-36 (Mental Component Summary)
−0.28 SF-36 (Physical Component Summary)
−0.20 EQ-VAS
SF-36: Short Form 36
HADS hospital anxiety and depression scale
WHOQOL World Health Organization quality of life
EQ-VAS EuroQoL visual analogue scale
EORTC-QLQ-BR23 EORTC quality of life questionnaire breast cancer module
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difficult for patients with colorectal or prostate cancer,
and for men, than for patients with breast cancer or
women, and in item 44 being more difficult for patients
with prostate cancer than for those with breast cancer.
Unidimensionality was supported in the Rasch analysis
for the four items of the benefits of cancer scale (Table 5).
The item separation index was 14.27, indicating good reli-
ability. The presence of DIF was not detected by type of
cancer, gender or age group (data not shown). Correlation
coefficients between residuals were all lower than 0.50,
supporting local independence, and the functioning of the
rating scale categories was adequate.
Fig. 1 Second-order confirmatory factor analysis for categorical data of the QLACS questionnaire. Standardized parameters are shown. NF:
Negative feelings; PF: Positive feelings; CP: Cognitive problems; SP: Sexual problems; PN: Pain; FG: Fatigue; SA: Social avoidance; AC: Appearance
concerns; FP: Financial problems; DOR: Distress over recurrence; FRD: Family-related distress; BOC: Benefits of cancer. Fit indexes are as follows:
RMSEA (90 % CI) = 0.061 (0.058 – 0.064); CFI = 0.929; TLI = 0.925
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Table 5 Severity levels, standard errors, and goodness-of-fit indices of the QLACS Generic and cancer-specific scales, and the benefits of
cancer and the sexual problems scales using Rasch analysis









You had the energy to do the things you wanted to do −0.16 0.03 1.23 1.28
Item 2 You had difficulty doing activities that require concentrating 0.38 0.04 0.77 0.84
Item 3 You were bothered by having a short attention span 0.27 0.04 1.20 1.12
Item 4 You had trouble remembering things −0.04 0.03 1.16 1.22
Item 5 You felt fatigued −0.19 0.03 0.83 0.85
Item 6 You felt happy −0.40 0.03 1.25 1.33
Item 7 You felt blue or depressed −0.09 0.03 0.87 0.94
Item 8 You enjoyed life −0.38 0.03 1.30 1.32
Item 9 You worried about little things −0.16 0.03 1.04 1.23
Item
10
You were bothered by being unable to function sexually Removed
Item
11
You didn’t have energy to do the things you wanted to do −0.07 0.03 0.82 0.81
Item
12
You were dissatisfied with your sex life Removed
Item
13
You were bothered by pain that kept you from doing the things you wanted to do −0.02 0.03 1.10 1.06
Item
14
You felt tired a lot −0.33 0.03 0.71 0.72
Item
15
You were reluctant to start new relationships Removed
Item
16
You lacked interest in sex Removed
Item
17
Your mood was disrupted by pain or its treatment 0.07 0.04 1.05 0.99
Item
18
You avoided social gatherings 0.32 0.04 1.26 1.17
Item
19
You were bothered by mood swings −0.15 0.03 0.80 0.86
Item
20
You avoided your friends 0.72 0.04 1.08 1.20
Item
21
You had aches or pains −0.04 0.03 1.03 1.05
Item
22
You had a positive outlook on life Removed
Item
23
You were bothered by forgetting what you stated to do 0.24 0.04 0.89 1.10
Item
24
You felt anxious −0.26 0.03 0.86 0.96
Item
25
You were reluctant to meet new people Removed
Item
26
You avoided sexual activity Removed
Item
27
Pain or its treatment interfered with your social activities 0.30 0.04 1.10 1.09
Item
28
You were content with your life Removed
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Table 5 Severity levels, standard errors, and goodness-of-fit indices of the QLACS Generic and cancer-specific scales, and the benefits of




You had financial problems because of the cost of cancer surgery or treatment Removed
Item
31
You worried that your family members were at risk of getting cancer −0.46 0.04 1.04 1.01
Item
33
You were self-conscious about the way you look because of your cancer or its treatment 0.40 0.04 1.18 1.10
Item
34
You worried about whether your family members might have cancer-causing genes −0.49 0.04 0.94 0.90
Item
35
You felt unattractive because of your cancer or its treatment 0.47 0.04 0.98 0.95
Item
36
You worried about dying from cancer −0.14 0.04 1.02 1.02
Item
37
You had problems with insurance because of cancer Removed
Item
38
You were bothered by hair loss from cancer treatment 0.59 0.04 1.28 1.23
Item
39
You worried about cancer coming back −0.55 0.04 0.81 0.83
Item
42
You worried about whether your family members should have genetic tests for cancer −0.22 0.04 1.26 1.17
Item
43
You had money problems that arose because you had cancer Removed
Item
44
You felt people treated you differently because of changes to your appearance due to your cancer or
its treatment
0.81 0.04 1.24 1.17
Item
45
You had financial problems due to a loss of income as a result of cancer Removed
Item
46
Whenever you felt a pain, you worried that it might be cancer again −0.14 0.03 0.85 0.95
Item
47
You were preoccupied with concerns about cancer −0.24 0.03 0.81 0.87
Benefits of cancer scale
Item
29
You appreciated life more because of having had cancer −0.38 0.03 1.15 1.15
Item
32
You realized that having had cancer helps you cope better with problems now 0.04 0.03 0.84 0.85
Item
40
You felt that cancer helped you to recognize what is important in life −0.45 0.03 0.77 0.73
Item
41




You were bothered by being unable to function sexually 0.10 0.03 1.12 1.07
Item
12
You were dissatisfied with your sex life 0.01 0.03 0.94 0.89
Item
16
You lacked interest in sex −0.09 0.03 0.98 0.90
Item
26
You avoided sexual activity −0.02 0.03 0.98 0.89
aReverse item
δ = level of severity (higher values indicate higher severity)
SE standard error, MNSQ mean square fit statistic
Item separation index of each model: 7.70 for the Generic scale, 11.89 for the cancer-specific scale, 14.27 for the benefits of cancer scale, and 2 for the sexual
problems scale
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Based on the results of Rasch analyses, we propose a
model in which four items were deleted (items 22 and 28
from PF and items 15 and 25 from SA), and the second-
order generic factor would not affect the SP first-order
factor, and the second-order specific factor would not
affect the FP first-order factor. The results of the second-
order CFA for this model (Fig. 2) provided satisfactory fit
indices and almost identical to those obtained for the ori-
ginal model (Fig. 1). The RMSEA was 0.061, and the CFI
and TLI values were 0.939 and 0.935, respectively.
Discussion
This study provides data from the classical psychometric
and Rasch approach on the validation of the Spanish
Fig. 2 Second-order confirmatory factor analysis for categorical data of the QLACS questionnaire after removing four items and removing some
relationships based on the results of Rasch analyses. Standardized parameters are shown. NF: Negative feelings; PF: Positive feelings; CP: Cognitive
problems; SP: Sexual problems; PN: Pain; FG: Fatigue; SA: Social avoidance; AC: Appearance concerns; FP: Financial problems; DOR: Distress over
recurrence; FRD: Family-related distress; BOC: Benefits of cancer. Fit indexes are as follows: RMSEA (90 % CI) = 0.061 (0.057 – 0.064); CFI = 0.939; TLI = 0.935
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version of the QLACS questionnaire. Although this ques-
tionnaire was developed for long-term cancer survivors,
the findings of this study showed that QLACS is a valid
and reliable instrument to be used in short-term cancer
survivors in Spanish population.
In the year 2008 [28], the need for psychometrically
credible quality of life instruments for cancer survivors
who were in 1–5 years post diagnosis phase had already
been detected. Although the QLACS questionnaire was
developed originally for long-term survivors, it has re-
cently demonstrated its usefulness in shorter-term cancer
survivors in its original language [8, 9]. As a consequence,
this study has tried to provide some information about the
reliability and validity of the QLACS questionnaire in an-
other language.
In terms of internal consistency, our Cronbach’s alphas
are in the range of 0.73–0.86 for all domains and sum-
mary scales. They are similar to values found in the ori-
ginal instrument that were between 0.72 and 0.91 [5]
and a bit lower than those reported by Ashley et al. [8]
that were between 0.75 and 0.95, in a sample of similar
characteristics of short-term cancer survivors and those
reported by Sohl et al. [9] which were in the 0.79–0.91
range, in short-term breast cancer survivors. Likewise,
all coefficients for item-domain and item-scale correla-
tions have shown adequate values and are higher than
the accepted values with the only exception of item 37.
On the other hand, test-retest reliability, measured in
stable patients, can be considered as appropriate in all
domains [17]. These facts seem to assure the reliability
of the instrument.
Although both summary scales are free from ceiling or
floor effects, our data show a floor effect (minimal score)
in four domains. Three of them: social avoidance, ap-
pearance concerns and financial problems showed the
same floor effect as in a previous validation work [8]
with the same cancer diagnosis carried out as well with
short-term survivors. In addition, in two of them: social
avoidance and financial problems, a recent work [9], has
found the same floor effect. In a sample of breast cancer
survivors [29], and in her original work [5], there also
were floor effects in appearance concerns and financial
problems. One possible explanation for the effect in so-
cial avoidance and appearance concerns domains could
be that cancer locations included in the study are not
the more problematic regarding physical problems 2–3
years post treatment. Possibly the acute appearance
problems which can influence social avoidance due to
the treatment effects have already been resolved in this
stage of the disease in these cancer locations. The floor
effect in financial problems possibly could be explained
because questions included in the questionnaire are
closely related to the cost of the disease, its treatment
and insurance plans, and in Spain these issues were, in
general, covered by the National Health Service. The
fourth dimension is pain, which shows values close to
the original work [5], the work of previous validation in
shorter-term survivors [8], another carried out with
breast cancer survivors [29] and with short-term breast
cancer survivors [9]. However, there was only one di-
mension with ceiling effect, family-related distress. One
possible explanation might be that the patients are in-
creasingly aware of the influence of genetics on the de-
velopment of some types of cancers.
Regarding feasibility, there were several items with
missing values above 5 %. As in the study of Ashley [8],
the four items of sexual problems domain, as well as
items 28 (positive feelings), 27 (pain) and 15 (social avoid-
ance presented missing data. It is well known that the
presence of missing data in sexual aspects is a frequent
finding in the research field. Regarding item 15, we agree
with the explanation given by Ashley et al. [8] about the
possible interpretation of the meaning of the item as sex-
ual instead of social relationships. We do not have a satis-
factory explanation for items 27 and 28.
The questionnaire seems to have good convergent val-
idity in the studied domains. As in the original work,
Generic domains have higher correlation coefficients
than Specific domains.
Our second-order CFA results indicate that the struc-
ture of the questionnaire does have adequate structural
validity. Considering the results of Rasch analysis for the
Generic scale, we found eight misfitting items: the four
items of sexual problems domain (items 10, 12, 16 and
26), two items of the positive feeling domain (items 22
and 28), and two items of the social avoidance domain
(items 15 and 25). Ashley et al. [8], in the only study in
which a Rasch analysis is applied to the questionnaire,
also find the four items of the sexual problems scale and
item 15 of the social avoidance domain to be problem-
atic. Regarding items 22 and 28 of the positive feeling
domain, the CFA results showed factor loadings for
these two items much lower than those of the other two
items in the same domain. Considering the results of the
Rasch analysis for the sexual problems domain separ-
ately, we found local dependency. Our results, suggested
the existence of two subscales, one of function (items 10
and 12) and another of interest (items 16 and 26). These
results agree with the results obtained by Ashley et al.
[8], and also with the results obtained by the original au-
thors [5], since in the exploratory factor analysis they
presented these four items in two separate factors.
Regarding the results of Rasch analysis for the cancer-
specific scale, we found the four items of the financial
problems scale to be misfit. This result does not agree
with those obtained by Ashley et al. [8]. Furthermore,
DIF was found for item 38 between patients with colo-
rectal or prostate cancer with respect to those with
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breast cancer, and between men and women. DIF was
also found in item 44 between patients with prostate
cancer and those with breast cancer.
Like Ashley et al. [8], we also found that all items of
the benefits of cancer scale showed fit to the Rasch
model, demonstrated unidimensionality, adequate item
separation index, and no DIF by gender, type of cancer
or age group.
This study has some limitations; it is centered on pa-
tients with breast, prostate or colorectal cancer, so the
results may not extrapolate to other cancer locations.
This study has been carried out with non-metastatic pa-
tients and without local-recurrence. Finally, we have
been unable to study convergent validity in all domains
due to the lack of adequate dimensions in other used
instruments.
Conclusions
The Spanish version of the Quality of Life in Adult Can-
cer Survivors (QLACS) has shown good reliability and
validity and the findings of this study support its use to
assess quality of life in short-term cancer survivors. As a
consequence, the questionnaire may be used to establish
quality of life in Spanish short-term survivors from
breast, prostate or colorectal cancer.
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